Bank of New York Mellon Corp lowered its position in shares of Israel Chemicals Ltd (NYSE:ICL) by 5.8% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 1,963,515 shares of the basic materials company’s stock after selling 121,385 shares during the quarter. Bank of New York Mellon Corp’s holdings in Israel Chemicals were worth $8,959,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently made changes to their positions in ICL. Stifel Financial Corp boosted its position in Israel Chemicals by 276.8% during the 1st quarter. Stifel Financial Corp now owns 45,338 shares of the basic materials company’s stock valued at $185,000 after buying an additional 33,305 shares during the period. Eqis Capital Management Inc. purchased a new stake in Israel Chemicals during the 2nd quarter valued at $245,000. A.R.T. Advisors LLC boosted its position in Israel Chemicals by 147.4% during the 1st quarter. A.R.T. Advisors LLC now owns 59,138 shares of the basic materials company’s stock valued at $250,000 after buying an additional 35,230 shares during the period. BlackRock Inc. boosted its position in Israel Chemicals by 13.9% during the 1st quarter. BlackRock Inc. now owns 113,993 shares of the basic materials company’s stock valued at $483,000 after buying an additional 13,942 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its position in Israel Chemicals by 29.9% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 144,534 shares of the basic materials company’s stock valued at $659,000 after buying an additional 33,274 shares during the period. 8.11% of the stock is owned by institutional investors and hedge funds.

Shares of ICL opened at $6.18 on Thursday. The firm has a market cap of $8.05 billion, a price-to-earnings ratio of 19.94 and a beta of 1.15. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.35 and a quick ratio of 0.76. Israel Chemicals Ltd has a twelve month low of $3.85 and a twelve month high of $6.30.

Israel Chemicals (NYSE:ICL) last announced its quarterly earnings results on Wednesday, August 1st. The basic materials company reported $0.09 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.08 by $0.01. The business had revenue of $1.37 billion during the quarter. Israel Chemicals had a net margin of 22.74% and a return on equity of 14.16%. The company’s quarterly revenue was up 3.7% on a year-over-year basis. During the same period in the previous year, the company earned $0.05 EPS. equities research analysts forecast that Israel Chemicals Ltd will post 0.36 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 4th. Stockholders of record on Tuesday, August 21st were given a $0.043 dividend. This represents a $0.17 annualized dividend and a dividend yield of 2.78%. This is a boost from Israel Chemicals’s previous quarterly dividend of $0.04. The ex-dividend date was Monday, August 20th. Israel Chemicals’s dividend payout ratio (DPR) is currently 32.26%.

Several equities research analysts have weighed in on ICL shares. Zacks Investment Research raised shares of Israel Chemicals from a “hold” rating to a “buy” rating and set a $5.25 price target for the company in a research report on Wednesday, July 11th. ValuEngine raised shares of Israel Chemicals from a “hold” rating to a “buy” rating in a research report on Friday, August 24th. Finally, BMO Capital Markets reissued a “hold” rating and set a $5.25 price target on shares of Israel Chemicals in a research report on Wednesday, September 19th. Two investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Israel Chemicals has a consensus rating of “Buy” and an average price target of $5.25.

Israel Chemicals Company Profile

Israel Chemicals Ltd. operates as a specialty minerals company worldwide. The company operates through two segments, Essential Minerals and Specialty Solutions. The company extracts potash from the Dead Sea; mines and produces potash, salt, and Polysulphate; and produces, markets, and sells pure magnesium and magnesium alloys, as well as produces dry carnallite and related by-products, including chlorine and sylvinite.

Featured Article: Intrinsic Value

Want to see what other hedge funds are holding ICL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Israel Chemicals Ltd (NYSE:ICL).

Institutional Ownership by Quarter for Israel Chemicals (NYSE:ICL)

Receive News & Ratings for Israel Chemicals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Israel Chemicals and related companies with MarketBeat.com's FREE daily email newsletter.